Navigation Links
'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign
Date:9/6/2007

Open Letter Print Ad to Appear Today in Major Indian Newspapers Includes Chart Comparing Cipla Drug Prices in India vs. Africa; AHF Urges Lower

Prices, Greater Access for Indians in Need

NEW DELHI, India, Sept. 6 /PRNewswire-USNewswire/ -- As part of its ongoing global campaign to lower drug prices and improve access to lifesaving HIV/AIDS treatments worldwide, AIDS Healthcare Foundation (AHF) has published a print advertisement in the form of an open letter that will appear in several prominent Indian newspapers today.

Headlined 'Cipla, Tell the Truth' this latest ad is scheduled to appear in the Mumbai editions of The Indian Express and The Financial Express today and in the Delhi editions within a few days and follows a month-long public dialogue regarding higher prices offered by Cipla for its generic HIV/AIDS drugs in India vs. Africa. The controversy was sparked by an earlier drug- pricing advocacy ad placed by AHF in Indian newspapers in August. Headlined 'Profit at What Cost? AIDS Drugs for All' the ad questioned a 150% price difference between what Cipla has offered African and Indian purchasers for the same lifesaving antiretroviral medication. Spurred by AHF's allegations, the Monopolies and Restrictive Trade Practices Commission (MRTPC), India's anti-trust commission that probes monopolistic, restrictive and unfair trade practices, recently began an investigation into Cipla's pricing practices.

"With this advertisement, we hope to put an end to the recent storm of controversy pitting AHF and Cipla against each other and to re-focus the public dialogue on what is most important: the fact that Cipla's HIV/AID drug prices are simply too high in India," said Chinkholal Thangsing, M.D., Asia Pacific Bureau Chief for the AIDS Healthcare Foundation and a medical provider based in New Delhi. "We also hope to refute baseless claims recently leveled at AHF regarding the motives behind our efforts to lower HIV/AIDS drug
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Healthcare sector is now a multi billion-dollar industry in India
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. Healthcare Professionals Might Want To Rethink Their Dress Code
4. WHO report asks for improved healthcare for mother and child
5. New X-ray machine launched by GE Healthcare
6. India To March Ahead in The Global HealthCare Competition
7. Medical Fraternity Urged To Revamp Indian Healthcare
8. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
9. Need For Social Churning Emphasized In CMC Meet On ‘Leadership In Healthcare
10. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
11. India Can Manage World’s Healthcare Crisis By 202
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...ios Spanos was shocked when his doctor discovered ... his body’s largest blood vessel, the aorta, durin...o symptoms, and was relieved to find out that the ...had been caught while it was still small. For the...
... A brewery in Japan launched production of unusual...farmer who was looking for ways to put his milk su...k will be available in the store shelves Thursday,...akashibetsu, on the country's northernmost island ...
... are planning to whiten your teeth by bleaching th...it done by unqualified people could cause consider...alons are offering teeth whitening by unqualified ...l bleach," said Christopher Orr, president of the ...
...tors and nurses who work in the developing world w...challenges, according to ‘Meeting the Health needs... The BMA’s International Committee surveyed 79 UK...including 67 doctors, who had recently worked in A...
Other Medicine News:Health News:Early Detection of Artery Weakening Can Be a Life-Saver 2Health News:Early Detection of Artery Weakening Can Be a Life-Saver 3Health News:Health Workers Need Better Preparation for Developing World 2
(Date:7/23/2008)...publication in July print edition of Clinical ...IANAPOLIS, July 23 /- A Roche Diagnos...-terminal pro-B-type natriuretic peptide,(NT-proBN...isk,stratification in predicting the risk of cardi...ed with non-steroidal anti-inflammatory drugs of,t...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...uly 22 /- Following a,thoro...d of Progen,Pharmaceuticals Limited (ASX: PGL; Nas...d the PI-88 phase 3 study in liver cancer. Progen ...xisting portfolio of compounds and,the company wil...d,opportunities through Merger & Acquisition activ...
(Date:7/22/2008)...uss Development Plan Completed Successfully, DUBL...rin Corporation,plc (NASDAQ: AMRN ) today announc... the U.S. Food and Drug Administration (FDA) to di...e treatment of,hypertriglyceridemia. Following the... 3 with AMR101 in hypertriglyceridemia., Dr. Decl...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 1Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 2Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 4Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 1Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 2Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 1Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 1China Bio Energy Reports Fiscal 2007 Financial Results 4324 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 3China Bio Energy Reports Fiscal 2007 Financial Results 4324 4China Bio Energy Reports Fiscal 2007 Financial Results 4324 5China Bio Energy Reports Fiscal 2007 Financial Results 4324 6China Bio Energy Reports Fiscal 2007 Financial Results 4324 7China Bio Energy Reports Fiscal 2007 Financial Results 4324 8China Bio Energy Reports Fiscal 2007 Financial Results 4324 9China Bio Energy Reports Fiscal 2007 Financial Results 4324 10China Bio Energy Reports Fiscal 2007 Financial Results 4324 11
...s Efficacy at Improving Glycemic Control and,Reduc..., Ill., June 23, 2007 /PRNewswire/ -- VeroScience,...rtner S2 Therapeutics,Inc., reported today the re...the overall and cardiovascular safety of Cycloset(...mesylate) in subjects,with type 2 diabetes. The st...
...--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCB...that new,data presented at an international influe...,s patented PBS-1 cell line outperforms,current ce...us,inside its cells. The most important step towar...against a targeted virus is the,ability to efficie...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6
...y Biotech Captia™ Varicella- Zoster Virus (VZV...s intended for the detection and quantitative dete...dividual serum specimens may be used for the deter...convalescent, may be used to demonstrate seroconve...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as
The Trinity Biotech Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody in human serum to Mumps for the determination of immunological experi
The DIAGNOSTIC AUTOMATION, INC. (DAI) Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Mumps virus in human sera. In
Medicine Products: